Bio corporation MedPacto announced on the 5th that executives, including CEO Seong-jin Kim and President Jeong-won Woo, purchased about 100,000 shares of the company stock in the market.
It has been three years since executives at MedPacto last engaged in stock buybacks, which occurred in January 2022 when CEO Seong-jin Kim purchased 1 billion won worth of company stock.
A total of six executives participated in this stock buyback, including Mrs. Young-won Kim, the wife of CEO Seong-jin Kim. CEO Kim acquired 31,882 shares, President Woo bought 30,000 shares, and other Deputy Minister-level executives along with Mrs. Young-won Kim bought a total of 40,946 shares, resulting in MedPacto executives and related personnel purchasing a total of 105,828 shares.
A MedPacto representative noted, "This stock buyback demonstrates the company's commitment to making responsible management and enhancing corporate value key objectives in management and research and development," adding, "We will communicate in the market to support the stock price while also strengthening shareholder-friendly policies."